Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 909-586-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation
- Remarks:
- in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented study which meets basic scientific principles
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Landsteiner-Draize Method. No more information.
- GLP compliance:
- no
- Type of study:
- other: Landsteiner / Draize method
Test material
- Reference substance name:
- Aluminium oxide
- EC Number:
- 215-691-6
- EC Name:
- Aluminium oxide
- Cas Number:
- 1344-28-1
- Molecular formula:
- Al2O3
- Details on test material:
- - Name of test material (as cited in study report): Aluminium oxide AK 43/79 and aluminium oxide AK 44/79
- Analytical purity: no data
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: albino SPF
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Central Institute for the Breeding of laboratory Animals, TNO, Zeist, The Netherlands
- Age at study initiation: young adult
- Weight at study initiation: 276 - 348 g
- Housing: animals were individually housed in suspended stainless steel cages, fitted with wire mesh floors and fronts
- Diet : all animals were fed stock diet (produced by Hope Farms, Woerden, The Netherlands), ad libitum. The composition of the diet and Al content are not provided (not a critical omission).
- Water: tap water ad libitum
- Acclimation period: 3 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 ± 1°C
- Humidity (%): 45 ± 5%
- Photoperiod (hrs dark / hrs light): Artificial light was used 12 hours daily from 6 a.m. to 6 p.m.
Randomization: Animals were randomly assigned to 4 treatment groups – two test groups and two control groups with 8 animals in each group.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: It was mentioned that both test compounds were administered as aqueous suspensions. No details were available on the preparation of test item for administration, however.
- Concentration / amount:
- The concentration 33.33% was selected based on the results of a preliminary study that showed that one intra-dermal injection of 0.1 ml of a 33.33% aqueous suspension induced a mild skin reaction. Therefore, a 33.33% dilution was used for the induction and challenge injections.
Challengeopen allclose all
- Route:
- intradermal
- Vehicle:
- other: It was mentioned that both test compounds were administered as aqueous suspensions. No details were available on the preparation of test item for administration, however.
- Concentration / amount:
- The concentration 33.33% was selected based on the results of a preliminary study that showed that one intra-dermal injection of 0.1 ml of a 33.33% aqueous suspension induced a mild skin reaction. Therefore, a 33.33% dilution was used for the induction and challenge injections.
- No. of animals per dose:
- Test groups: 8 animals;
Control group: 8 animals. - Details on study design:
- RANGE FINDING TESTS:
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 10 intra-dermal injections
- Site: on the right flank within an area of 3 x 4 cm
- Frequency of applications: 3 times weekly for 3 weeks
- Concentrations: During the first injection, each animal received 0.05 ml of the administered solution, in the second to the tenth injections 0.1 ml was administered to each animal
- The injection sites were examined 24 hours after the injection.
B. CHALLENGE EXPOSURE
- Concentrations: 0.05 ml of the 33.33% diluted test sample
- Evaluation (hr after challenge): 2 weeks after the last injection
- The reaction sites were examined 24 hours after the injection.
OTHER:
Observations
Data on body weights, mortality and signs of systemic toxicity during the study are not available.
Skin reactions:
The test compounds caused mild (after 1 to 7 injections in 8 animals) to moderate (after 8 injection in 2 animals, after 9 injection in 4 animals and after 10 injections in 8 animals) skin reactions during the induction period. - Challenge controls:
- The control animals were treated at the same time as test animals with 0.05 ml of the 33.33% dilution of the each test sample.
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- not applicable
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 33.33%
- No. with + reactions:
- 8
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 33.33%. No with. + reactions: 8.0. Total no. in groups: 8.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 33.33%
- No. with + reactions:
- 8
- Total no. in group:
- 8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 33.33%. No with. + reactions: 8.0. Total no. in groups: 8.0.
Any other information on results incl. tables
Test groups (8 animals)
AK 43/79
After the challenge dose of AK 43/79, all animals from this group developed a mild skin reaction.
AK 44/79
The challenge dose of AK 44/79 provoked mild reaction in 6 animals and moderate reaction in 2 animals.
Control group (8 animals)
AK 43/79 (controls)
After the challenge dose of AK 43/79, the control animals showed a mild reaction in 7 and a moderate reaction in 1 animal.
AK 44/79 (controls)
The challenge dose of AK 44/79 provoked 7 mild reactions and 1 moderate reaction.
No significant differences were reported between both test compounds and the control animals with respect to the degree and incidence of erythema and oedema.
Individual data are provided in Table 1 and 2 of the report.
Table 1. Individual positive reactions (marked with + signs) observed during the induction and challenge period with AK 43/79
Test animals |
Control animals |
||||||||||||
No. |
Individual direct reaction |
challenge |
No. |
Reaction to injection at the same time as the challenge |
|||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
||||
2278 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
+ |
2286 |
+ |
2279 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
+ |
2287 |
+ |
2280 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
+ |
2288 |
+ |
2281 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
+ |
2289 |
++ |
2282 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
+ |
2290 |
+ |
2283 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
+ |
2291 |
+ |
2284 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
+ |
2292 |
+ |
2285 |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
+ |
2293 |
+ |
2298 |
|
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
++ |
+ |
2306 |
+ |
2299 |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
++ |
+ |
2307 |
+ |
2300 |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
+ |
++ |
++ |
++ |
2308 |
++ |
2301 |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
+ |
2309 |
+ |
2302 |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
++ |
+ |
2310 |
+ |
2303 |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
++ |
+ |
2311 |
+ |
2304 |
+ |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
+ |
2312 |
+ |
2305 |
+ |
+ |
+ |
+ |
+ |
++ |
++ |
++ |
++ |
++ |
++ |
2313 |
+ |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Based on the reaction to the challenge dose, it can be concluded that Al oxide AK 43/79 and Aluminium oxide AK 44/79 has no sensitisation potential under the experimental conditions.
- Executive summary:
The skin sensitisation potential of two samples aluminium oxide, namely aluminium oxide TBH: AK 43/79 and aluminium oxide TOF: AK 44/79, was assessed in guinea pigs (male albino SPF, 8 animals in each group) using the Landsteiner/Draize method (Central Institute for Nutrition and Food Research, Germany) at the request of Degussa AG, Germany (1979). Both compounds were administered by intra-dermal injections. A 33.3% aqueous suspension was used in both the induction and challenge phases. During the induction phase, the test animals received 10 intra-dermal injections of the test suspension, 3 times per week over a 3 week period. The test suspensions were administered to different shaved spots on the right flank of the animals within an area of 3 x 4 cm. The injected volume was 0.05 mL for the first injection and 1.0 mL for subsequent. The control group received a single injection during this phase. The injection sites were examined 24 hours after the injection and the diameter, colour and thickness of any lesions were used as criteria for the intensity of the reaction. In the induction phase,following 1 to 7 injections of AK 43/79, all animals showed mild reactions. Two animals showed moderate reactions after the 8th injection, an additional 2 animals showed moderate reactions after the 9th injection and all 8 animals showed a moderate reaction after the 10th injection. Data were provided on any skin reactions on the single injection received by the control animals. For AK 44/79, all reactions were mild until after the 6th injection when 5 animals showed a moderate reaction. All animals showed moderate reactions
after the 7th to 10th injections. Two weeks after the last injection, guinea pigs from both test groups and the control group received the challenge dose in the amount of 0.05 mL per animal. The reaction sites were examined 24 hours after the injection.After the challenge dose of AK 43/79, all animals exposed during the induction period developed a mild skin reaction. A mild reaction was also found in 7 and a moderate reaction in 1 of the animals in the control group. The challenge dose of AK 44/79 provoked a mild reaction in 6 animals and moderate reaction in 2 animals exposed during the induction period. In the control animals, 7 mild reactions and 1 moderate reaction were observed. No significant differences were observed between the test and control animals with respect to the degree and incidence of erythema and oedema. Under the conditions of this test, aluminium oxide AK 43/79 and aluminium oxide AK 44/79 are not skin sensitizers (Landsteiner/Draize test, guinea pig).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.